278 related articles for article (PubMed ID: 16011141)
1. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
Khanna P; Shah A
Am J Rhinol; 2005; 19(3):316-21. PubMed ID: 16011141
[TBL] [Abstract][Full Text] [Related]
2. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
Bachert C; El-Akkad T
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
Stokes M; Amorosi SL; Thompson D; Dupclay L; Garcia J; Georges G
Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
[TBL] [Abstract][Full Text] [Related]
4. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
[TBL] [Abstract][Full Text] [Related]
6. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis.
Mahadevia PJ; Shah S; Leibman C; Kleinman L; O'Dowd L
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):345-50. PubMed ID: 15521370
[TBL] [Abstract][Full Text] [Related]
7. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
8. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
Meltzer EO; Bardelas J; Goldsobel A; Kaiser H
Treat Respir Med; 2005; 4(4):289-96. PubMed ID: 16086602
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergic rhinitis.
Baena-Cagnani CE; Patel P
Curr Med Res Opin; 2010 Sep; 26(9):2047-55. PubMed ID: 20629597
[TBL] [Abstract][Full Text] [Related]
12. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
Yonezaki M; Akiyama K; Karaki M; Goto R; Inamoto R; Samukawa Y; Kobayashi R; Kobayashi E; Hoshikawa H
Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699
[TBL] [Abstract][Full Text] [Related]
13. Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray.
Shah SR; Miller C; Pethick N; Uryniak T; Jones MK; O'Dowd L
Clin Ther; 2003 Aug; 25(8):2198-214. PubMed ID: 14512128
[TBL] [Abstract][Full Text] [Related]
14. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?
Waddell AN; Patel SK; Toma AG; Maw AR
J Laryngol Otol; 2003 Nov; 117(11):843-5. PubMed ID: 14670141
[TBL] [Abstract][Full Text] [Related]
15. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
Derendorf H; Meltzer EO
Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
[TBL] [Abstract][Full Text] [Related]
16. A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.
Berger WE; Prenner B; Turner R; Meltzer EO
Allergy Asthma Proc; 2013; 34(6):542-50. PubMed ID: 24169063
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sensory attributes and immediate efficacy of intranasal ciclesonide and fluticasone propionate in allergic rhinitis: a randomized controlled trial.
Varshney J; Varshney H; Dutta SK; Hazra A
Indian J Pharmacol; 2012; 44(5):550-4. PubMed ID: 23112411
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
May JR; Dolen WK
Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
[TBL] [Abstract][Full Text] [Related]
19. Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis.
Ratner PH; Meltzer EO; Teper A
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):651-7. PubMed ID: 19233485
[TBL] [Abstract][Full Text] [Related]
20. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?
Yawn B
MedGenMed; 2006 Jan; 8(1):23. PubMed ID: 16915153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
